Physician profile
Hoon C Jung
NPI 1164521688
$2,234.00
in general payments reported to CMS, 2019-2025
9 companies · $904 in 2025
The $904 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $67.81 · 2023: $681 · 2024: $420 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,593.75 | 2021-2025 | Idosetr, Istent Infinite, Istent |
| Rxsight INC | $270.92 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $162.36 | 2022-2024 | Clareon, Acrysof, Iq Restor |
| Abbvie INC. | $98.91 | 2024-2025 | |
| Biotissue Holdings INC. | $36.38 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $19.11 | 2022 | |
| Rayner Intraocular Lenses Limited | $18.90 | 2022 | |
| Merck Sharp & Dohme LLC | $17.92 | 2025 | Bridion |
| Bausch & Lomb Americas INC. | $15.75 | 2023 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoon Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.